213 related articles for article (PubMed ID: 17852889)
1. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
[TBL] [Abstract][Full Text] [Related]
2. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections.
Baré M; Castells X; Garcia A; Riu M; Comas M; Egea MJ
Int J Technol Assess Health Care; 2006; 22(2):242-8. PubMed ID: 16571200
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.
Sturkenboom MC; Goettsch WG; Picelli G; in 't Veld B; Yin DD; de Jong RB; Go PM; Herings RM
Br J Clin Pharmacol; 2005 Oct; 60(4):438-43. PubMed ID: 16187977
[TBL] [Abstract][Full Text] [Related]
4. Cost of care for inpatients with community-acquired intra-abdominal infections.
Cattan P; Yin DD; Sarfati E; Lyu R; De Zelicourt M; Fagnani F
Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):787-93. PubMed ID: 12461588
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
7. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
8. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
9. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
[TBL] [Abstract][Full Text] [Related]
10. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study.
McLaughlin CM; Bodasing N; Boyter AC; Fenelon C; Fox JG; Seaton RA
QJM; 2005 Oct; 98(10):745-52. PubMed ID: 16126741
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
[TBL] [Abstract][Full Text] [Related]
12. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
13. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery.
Krobot K; Yin D; Zhang Q; Sen S; Altendorf-Hofmann A; Scheele J; Sendt W
Eur J Clin Microbiol Infect Dis; 2004 Sep; 23(9):682-7. PubMed ID: 15322931
[TBL] [Abstract][Full Text] [Related]
14. Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?
Wilson SE; Turpin RS; Hu XH; Sullivan E; Mansley EC; Ma L
Am Surg; 2005 Oct; 71(10):816-20. PubMed ID: 16468526
[TBL] [Abstract][Full Text] [Related]
15. Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes.
Borer A; Gilad J; Meydan N; Schlaeffer P; Riesenberg K; Schlaeffer F
Clin Microbiol Infect; 2004 Oct; 10(10):911-6. PubMed ID: 15373886
[TBL] [Abstract][Full Text] [Related]
16. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
Mettler J; Simcock M; Sendi P; Widmer AF; Bingisser R; Battegay M; Fluckiger U; Bassetti S
BMC Infect Dis; 2007 Mar; 7():21. PubMed ID: 17386104
[TBL] [Abstract][Full Text] [Related]
17. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
18. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
Bratzler DW; Ma A; Nsa W
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
Goldstein EJ; Snydman DR
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii29-36. PubMed ID: 15150181
[TBL] [Abstract][Full Text] [Related]
20. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
Opmeer BC; El Moussaoui R; Bossuyt PM; Speelman P; Prins JM; de Borgie CA
J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
